`
Monday, 26 June 2017

India News

  • Novo Nordisk insulin top pharma product in India

    India |  Analysis | By Saptarshi Chaudhuri | 0 Comment | 11 Jun, 2012

    India, which has the second largest population in the world and is among the top three nations in terms of patient pool, secured revenues of $10.6 billion in 2011 as compared to $10.3 billi...Read more

  • Zydus Cadila: A year of unparalleled growth

    India |  Analysis | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2015

    Singapore:  Cadila Healthcare, India Chairman: Mr Pankaj R PatelRevenue: $1285.6 mnBusiness: Discovery, development, manufacturing and marketing of healthcare products   Cadila Healthc...Read more

  • ABIVAX to market typhoid, meningococcus vaccines in Asia

    India |  News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2014

    Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compounds and human vaccines, has collaborated with Finlay Institute, Hava...Read more

  • India continues to lead China in pharma exports

    India |  News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2016

    Singapore: India has maintained its lead over China in terms of pharma exports, according to a statement by the ministry of commerce and industry. The country's pharma rose grew 7.55 perce...Read more

  • LifeCell offers Dual Storage of stem cells

    India |  News | By BioSpectrum Bureau | 0 Comment | 21 Dec, 2012

    Singapore: LifeCell International, India's largest stem cell storage company, announced the launch of India's first Dual Storage service that allows stem cells to be stored at two geographi...Read more

  • Wockhardt increases investment in R&D

    India |  News | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2015

    Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plans to further strengthen its research and development capabilities and...Read more

  • Eli Lilly's corporate social responsibility impact

    India |  Opinion | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013

    For more than 135 years, Eli Lilly and Company has demonstrated a commitment to be a responsible global citizen, in large part, through a long history of philanthropic contributions. Our gr...Read more

  • Europe plants €3.7 billion in bio-based economy

    India |  News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2014

    Singapore: European Commission president Mr José Manuel Barroso, and Commissioner for Research, Innovation and Science, Ms Máire Geoghegan-Quinn, announced the formal launch of a â...Read more

  • Glenmark bags FDA approval for skin ointment

    India |  News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2016

    Singapore: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Triamcinolone Acetonide Ointment USP...Read more

  • Lupin gets FDA nod for generic Ortho Tri-cyclen Lo Tablets

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2012

    Mumbai: Mumbai-based pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received approval for its Norgestimate and Ethinyl Estradiol Tablets, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, a...Read more

  • Lupin inks strategic JV agreement with Yoshindo

    India |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014

    Singapore: Pharma Major, Lupin Limited announced today that it has entered into a strategic joint venture agreement with Toyama based Japanese pharmaceuticals company, Yoshindo Inc. (Yoshin...Read more

  • Ten top Indian life science collaborations of 2012

    India |  Analysis | By Vipul Murarka | 0 Comment | 26 Mar, 2013

    As the market for new drugs evolves, the methodologies for moving them into the market is changing and becoming more complex. Companies are increasingly relying on efficient collaboration s...Read more

  • APAC multiple myeloma market to value $2.8 bn by 2021: Report

    India |  Analysis | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2015

    Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from USD1.7 billion in 2014 to USD2.8 ...Read more

  • India slashes prices of 54 essential drugs

    India |  News | By BioSpectrum Bureau | 0 Comment | 12 May, 2016

    Singapore: With a view to make medicines for critical diseases more affordable, India's National Pharmaceutical Pricing Authority ( NPPA ) has slashed prices of 54 essential medicines by up...Read more

  • Baxter erects global R&D center at Syngene

    India |  News | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2014

    Bangalore: Baxter has constructed its R&D center at Biocon's Syngene facility. The facility, which was developed as a collaborative effort between the two organizations, has been name...Read more

  • India's Biological E to buy French Valneva's CMO unit

    India |  News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2013

    Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-based Biological E. The sale of this unit, which is dedicated to the ...Read more

  • Lupin gets 16 FDA nods, launches 11 products front

    India |  Analysis | By Amrita Tejasvi | 0 Comment | 04 Jun, 2013

    US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FDA and launched 11 products during 2012. Besides building a strong gri...Read more

  • FDA approves Sun Pharma's generic Prandin

    India |  Regulatory | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013

    Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Industries for releasing its diabetes generic Prandin. Making the announce...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls